Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer

Authors:

Abstract
Targeting epigenetic regulators is a promising therapeutic strategy against cancer. However, because of the broad spectrum of targets, selective inhibition
Funding Information
  • Chugai Co., Ltd.
  • Evidence Based Medical (EBM) Research Center
  • Yakult Honsha Co., Ltd.
  • Ministry of Health, Labor and Welfare
  • Merck Co., Ltd.
  • Unitech Co., Ltd.
  • Ministry of Education, Culture, Sports, Science and Technology
  • Osaka University Drug Discovery Funds
  • National Institute of Biomedical Innovation
  • Taiho Pharmaceutical Co., Ltd.

This publication has 30 references indexed in Scilit: